ASH Annual Meeting

ASH Annual Meeting

Highlights and interviews from the American Society of Hematology’s Annual Meeting

Iron Chelation Therapy With Deferasirox Improves Survival Over Placebo in Lower-Risk MDS

In patients with lower-risk myelodysplastic syndromes (MDS) and iron overload (IO), treatment with iron chelation therapy (ICT) deferasirox was associated with longer event-free survival...

Elotuzumab Combination Prevents Progression from Smoldering to Symptomatic Myeloma

In a phase II trial of patients with high-risk smoldering multiple myeloma (SMM), 84 percent of participants responded to treatment with elotuzumab, lenalidomide, and...

Combination of Daratumumab and Bortezomib-Based Regimen Safe in Newly Diagnosed Myeloma

The combination of two proven-effective treatment regimens, daratumumab and the combination of bortezomib, lenalidomide, and dexamethasone (VRd), was considered safe for patients with transplant-eligible,...

BELIEVE Trial: Luspatercept Lowers Transfusion Burden in Adults With Beta-Thalassemia

Patients with beta-thalassemia who received treatment with luspatercept had lower transfusion burdens, compared with those receiving placebo, according to findings from the randomized, double-blind,...

Every Patient Tells a Story: Using Narrative Medicine to Cure Disease

As part of the Education Program at the 2018 ASH annual meeting, three physician-writers will offer their take on the intersection of storytelling, writing,...

Myeloma Therapy: From Diagnosis to Relapse

This year’s Education Program takes a new approach to disease-specific content: In two Special Education Sessions, “Approach to the Treatment of the Young, Fit...

ASH-a-Palooza: Trainee Day. Reimagined.

The “Trainee Day” that attendees may know from past annual meetings has been reimagined as ASH-a-Palooza – a new educational experience that will offer...

Serving the Next Generation of Hematologists: Interview with Reed E. Drews, MD

Reed E. Drews, MD, recipient of the 2018 Mentor Award in education, explains how he found his home at Beth Israel Deaconess Hospital, Boston...

For the Love of the Lab: Interview with John E. Dick, PhD

John E. Dick, PhD, recipient of the 2018 Mentor Award in basic science, tells us about his career in the lab – from working...

Get Your Blood Pumping: High-Performance Hematology

In the “High-Performance Hematology: Elite Athletes and Weekend Warriors” session in this year’s Education Program, session chair Stephan Moll, MD, PhD, and speakers will...
Advertisement

Current Issue

January 2019 Annual Meeting Edition

This issue features highlights from the 2018 ASH Annual Meeting, including big data initiatives to improve prognosis in myelodysplastic syndromes, and more.